NFE2L2 and acute kidney injury: Additionally, our results align with a previous study that highlights the protective effect of a cuproptosis inhibitor (ammonium tetrathiomolybdate) against cisplatin-induced acute kidney injury, mainly via the activation of the NRF2 signaling pathway and relieving oxidative stress [51].